Cascio et al., 1985 - Google Patents
N-Phenylpiperazine derivatives with hypocholesterolemic activityCascio et al., 1985
- Document ID
- 8365449168834145884
- Author
- Cascio G
- Manghisi E
- Porta R
- Fregnan G
- Publication year
- Publication venue
- Journal of medicinal chemistry
External Links
Snippet
A series of new 4-(4-phenyl-l-piperazinyl)-l-(4-fluorophenyl)-2-(acyloxy)-l-butanones and 4- aryl-5-[oi-(4-aryl-lpiperazinyl) alkyl]-l, 3-dioxol-2-ones were synthesized and tested preliminarily for hypolipemic activity. Plasma cholesterol-lowering activity in normalrats was …
- 230000000871 hypocholesterolemic 0 title abstract description 10
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicylo [3.2.2.] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicylo [3.2.2.] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicylo [3.2.2.] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicylo [3.2.2.] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/02—Five-membered rings
- C07D339/04—Five-membered rings having the hetero atoms in position 1,2, e.g. lipoic acid
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Emmanuel‐Giota et al. | Synthesis and biological evaluation of several 3‐(coumarin‐4‐yl) tetrahydroisoxazole and 3‐(coumarin‐4‐yl) dihydropyrazole derivatives | |
US4840951A (en) | Novel naphthalene derivative | |
US5646149A (en) | Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents | |
JP2703408B2 (en) | 1,4-benzothiazepine derivatives | |
DE3608032A1 (en) | NEW, SULFURIZED 5-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF | |
EP0106565B1 (en) | Leukotriene antagonists, their production, and compositions containing them | |
JPH0641455B2 (en) | Pyridazinone derivative | |
PT674626E (en) | SELECTIVE INHIBITION COMPOUNDS OF AROMATASE. | |
US4866058A (en) | Method for control of hyperlipidemia | |
EP0388309B1 (en) | 1H,3H,7-pyrrolo [1,2-c] thiazolecarboxamides, their preparation and pharmaceutical compositions containing them | |
FR2595695A1 (en) | N - ((((2-HYDROXYHYL) PHENYL) (PHENYL) METHYLENE) AMINO-2) ETHYL) ACETAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE | |
CZ280084B6 (en) | Derivatives of 2-(aminoalkyl)-5-(arylalkyl)-1,3-dioxanes, process for their preparation and pharmaceutical preparation in which said derivatives are comprised | |
Cascio et al. | N-Phenylpiperazine derivatives with hypocholesterolemic activity | |
Campiani et al. | New pyrrolobenzothiazepine derivatives as molecular probes of the ‘peripheral-type’benzodiazepine receptor (PBR) binding site | |
BE1007245A3 (en) | Di-substituted derivatives of n, n'-ditrimethoxybenzoyle piperazine, a process for their preparation and therapeutic compositions containing. | |
EP0115979A1 (en) | Derivatives of 1H,3H-pyrrolo(1,2-c)thiazole, their preparation and pharmaceuticals containing them | |
FR2601011A1 (en) | NEW AGONISTIC TRICYCLIC DERIVATIVES OF CHOLINERGIC RECEPTORS AND MEDICAMENTS CONTAINING SAME | |
CA1209995A (en) | Process for preparing n-substituted nicotinamide 1-oxide compounds and the salts thereof; compounds and salts thus obtained | |
HU192653B (en) | Process for the production of imidazo /1,2-c/pyrimidines, as well as of therapeutic preparations containing these compounds as agent | |
US4946963A (en) | Compounds for the control of hyperlipidemia using N-substituted isoxazolidine-3,5-diones | |
CA1298294C (en) | Pyrrole derivatives, their preparation and their pharmaceutical compositions therein | |
US4105764A (en) | 4,5-Dihydro-5-oxopyrazolo[1,5-A]quinazoline-3-carboxamides | |
JPS58210088A (en) | Antiatherosclerotic azafurochromone | |
EP0002401B1 (en) | Derivatives of naphthalene, process for their preparation and their therapeutic application | |
US5192761A (en) | 1,2,4-triazolidine-3,5-diones and 1,3,5-triazine-2,4(1-H,3H)-diones, pharmaceutical compositions |